Skip to main content

Find Clinical Trials

Home
Conditions
Lipid Metabolism Disorders

Clinical trial condition

Lipid Metabolism Disorders

Explore clinical trials studying Lipid Metabolism Disorders. Study availability and eligibility vary by location and protocol.

3,309 public trials 330 recruiting studies

Refine in advanced search Browse all conditions

Lipid Metabolism Disorders trial results

Completed

Effect of Diet on Men and Women With Genetic Alterations Associated With Abnormal Blood Tests

NCT00108212

Conditions: Dyslipidemia, Dyslipidemias, Inflammation, +5 more
Locations: VA Maryland Health Care System Baltimore, Maryland, United States

View Trial Details

Completed

Effect of Gemfibrozil on Serum Glycosylphosphatidylinositol (GPI) Phospholipase D and Triglycerides

NCT00108511

Conditions: Dyslipidemias, Hyperlipidemias, Hypertriglyceridemia, +3 more
Locations: Roudebush VA Medical Center Indianapolis, Indiana, United States

View Trial Details

Completed

The Effect of Altering Colonic Microflora After Fiber (FOS) Consumption

NCT00516594

Conditions: Cardiovascular Disease, Cardiovascular Diseases, Diet Therapy, +6 more
Locations: Clinical Nutrition & Risk Factor Modification Centre, St. Michael's Health Centre Toronto, Ontario, Canada

View Trial Details

Completed

Barley Protein and CVD

NCT00334308

Conditions: Cardiovascular Disease, Cardiovascular Diseases, Diet Therapy, +6 more
Locations: St. Michael's Hospital Toronto, Ontario, Canada

View Trial Details

Completed

The Effects of Atorvastatin on Vulnerable Plaques in Untreated Dyslipidemic Patients.

NCT00172419

Conditions: Dyslipidemias, Hyperlipidemia, Hyperlipidemias, +6 more
Locations: National Taiwan University Hospital Taipei, Taiwan

View Trial Details

Completed

Fluvastatin 80 mg Ret. vs Combination With Ezetimibe 10 mg in Patients With High Cardiovascular Risk

NCT00814723

Conditions: Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
Locations: Depart. of Internal Medicine, Medical University of Graz Graz, Austria

View Trial Details

Completed

Dose-Ranging Study Evaluating AVE1625 in Abdominally Obese Patients With Atherogenic Dyslipidemia

NCT00345410

Conditions: Body Weight, Dyslipidemia, Dyslipidemias, +9 more
Locations: Sanofi-Aventis Administrative Office Bridgewater, New Jersey, United States

View Trial Details

Completed

A Study Evaluating the Safety and Efficacy of AVE5530 (4 Weeks) in Patients With Mild to Moderate Hypercholesterolemia

NCT00440154

Conditions: Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
Locations: Sanofi-Aventis Administrative Office Santiago, Chile

Sanofi-Aventis Administrative Office Budapest, Hungary

Sanofi-Aventis Administrative Office México, Mexico

Sanofi-Aventis Administrative Office Moscow, Russia

View Trial Details

Completed

LDL-Cholesterol Lowering Effect of KB2115 as Add on to Statin

NCT00593047

Conditions: Dyslipidemia, Dyslipidemias, Hypercholesterolemia, +4 more
Locations: Carl-Peter Anderberg Gothemburg, Sweden

View Trial Details

Completed

LDL-Cholesterol Lowering Effect of KB2115 as Add on to Ezetimibe

NCT00677248

Conditions: Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +4 more
Locations: Karo Bio AB Huddinge, Sweden

View Trial Details